Dr. Bettina Hamelin, President of Innovative Medicines Canada, gives insights into the adoption of innovative technologies, domestic supply chain for pharmaceuticals, and excluding medicines as retaliatory measures for tariffs.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe